Bicalutamide 150 Mg Oral Tablet

DRUG2 trials

Sponsors

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, University of Florida

Conditions

COVID-19SARS-CoV 2

Phase 2

Trial to Promote Recovery From COVID-19 With Endocrine Therapy

WithdrawnNCT04374279

Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsCOVID-19, SARS-CoV 2

Start: 2021-04-30End: 2022-01-31Updated: 2021-03-05

Phase 3

Bicalutamide to Block TMPRSS2 in Males With COVID-19 Infection

WithdrawnNCT04509999

University of FloridaCOVID-19

Start: 2020-10-26End: 2021-06-30Updated: 2021-07-01

Related Papers

Abstract IA09: A phase II trial to promote recovery from COVID-19 with endocrine therapy

Clinical Cancer Research2020-09-15